Royal Bank of Canada »

Predictive Oncology shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Predictive Oncology (POAI) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Predictive Oncology

Tip: Access up to 7 years of quarterly data

All positions including Predictive Oncology held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Predictive Oncology by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 50 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Predictive Oncology

Vanguard Group
Geode Capital Management
Susquehanna International
State Street Corporation
Csenge Advisory Group
Carnegie Mellon University
Tower Research Capital
Wells Fargo & Company
Advisor Group Holdings
PSI Advisors
National Bank Of Canada /fi/
Bank of America Corporation
Royal Bank of Canada

View all funds holding Predictive Oncology